Siponimod Improves MRI Outcomes in Patients With Secondary Progressive MSNovember 22, 2017Multiple Sclerosis
Durable Improvements in Clinical Outcomes With Alemtuzumab: Seven-Year Follow-UpNovember 2, 2017Multiple Sclerosis
Oligoclonal Bands Could Be a Valuable Criterion for the Diagnosis of MSOctober 25, 2017Multiple Sclerosis
The Diagnostic Value of 2010 McDonald Criteria Versus 2016 MAGNIMS Guidelines for Special MS PopulationsOctober 25, 2017Multiple Sclerosis
Serum Neurofilament Light Levels May Reflect the Efficacy of MS Treatments October 24, 2017Multiple Sclerosis
